OQROGet OQRO Pro
Insider trade

Thermo Fisher Scientific (TMO)Officer sold ~$49K

Joseph R. Holmes, Officer at Thermo Fisher Scientific, sold ~$49K of Thermo Fisher Scientific shares.

~$49K
Approx. value · 100 sh @ $492.62
2,603.98
Holds after · shares reported
Traded
Aug 29, 2025
Filed
Sep 2, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Oct 29, 2024CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  2. Dec 11, 2024CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  3. Mar 3, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  4. Jun 6, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  5. Jun 10, 2025CongressDisclosed partial sale of TMO — reported range $1,001 - $15,000
  6. Jun 30, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL
  7. Jul 2, 2025FDAFDA device approval: Oncomine Dx Express Test
  8. Jul 21, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  9. Jul 22, 2025CongressDisclosed purchase of TMO — reported range $1,001 - $15,000
  10. Jul 25, 2025InsiderOfficer sold ~$192K of TMO shares in the open market
  11. Jul 29, 2025Layoff notice · 5823 Newton Dr Carlsbad CA 92008Layoff notice filed in CA: 52 employees
  12. Jul 29, 2025Layoff notice · 5781 Van Allen Way Carlsbad CA 92008Layoff notice filed in CA: 33 employees
  13. Aug 6, 2025Insider · 1 personInsiders: 15 sales (~$4.5M)
  14. Aug 7, 2025Insider · 1 personInsiders: 5 sales (~$3.6M)
  15. Aug 19, 2025InsiderCEO sold ~$101K of TMO shares in the open market
  16. Aug 19, 2025Congress · 1 personMembers of Congress: 4 sales
  17. Aug 20, 2025Insider · 1 personInsiders: 2 sales (~$148K)
  18. Aug 22, 2025Insider · 1 personInsiders: 3 sales (~$5.0M)
  19. Aug 28, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL
  20. Aug 29, 2025 · this disclosureInsiderOfficer sold ~$49K of TMO shares in the open market

What came next

  1. Aug 29, 2025InsiderOfficer sold ~$140K of TMO shares in the open market
  2. Sep 5, 2025FDAFDA device clearance: The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mL
  3. Sep 5, 2025Insider · 1 personInsiders: 3 sales (~$200K)
  4. Sep 23, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  5. Sep 25, 2025FDAFDA device clearance: The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mL
  6. Oct 7, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  7. Oct 22, 2025Company filing · Form 8-K · ResultsReported its results
  8. Oct 24, 2025Insider · 2 peopleInsiders: 6 sales (~$10.0M)
  9. Oct 27, 2025Insider · 1 personInsiders: 11 sales (~$4.1M)
  10. Oct 30, 2025Congress · 1 personMembers of Congress: 1 purchase, 1 sale
  11. Oct 31, 2025CongressDisclosed sale of TMO — reported range $1,001 - $15,000
  12. Nov 7, 2025Insider · 1 personInsiders: 2 sales (~$5.8M)
  13. Nov 10, 2025Insider · 1 personInsiders: 2 sales (~$1.7M)
  14. Nov 12, 2025InsiderOfficer sold ~$622K of TMO shares in the open market
  15. Nov 13, 2025InsiderOfficer sold ~$2.76M of TMO shares in the open market
  16. Nov 24, 2025Company filing · Form 8-K · Material agreement, Other newsSigned an important agreement, and reported other company news
  17. Nov 25, 2025Insider · 1 personInsiders: 2 sales (~$6.4M)
  18. Dec 1, 2025InsiderOfficer sold ~$4.13M of TMO shares in the open market
  19. Dec 2, 2025Insider · 2 peopleInsiders: 2 sales (~$21.5M)
  20. Dec 3, 2025Insider · 1 personInsiders: 2 sales (~$18.7M)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Thermo Fisher Scientific

For Thermo Fisher Scientific, OQRO holds 93 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 143 fund holdings reports (13F) and 6 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TMO page.

Other recent filings by Joseph R. Holmes, VP & Chief Accounting Officer

The full history of Joseph R. Holmes, VP & Chief Accounting Officer is on the profile page.

How this filing works

Other disclosures at Thermo Fisher Scientific

Everything OQRO holds on this company is on its TMO page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data